353 related articles for article (PubMed ID: 12172137)
1. Outcome of patients with toxic epidermal necrolysis syndrome revisited.
Ducic I; Shalom A; Rising W; Nagamoto K; Munster AM
Plast Reconstr Surg; 2002 Sep; 110(3):768-73. PubMed ID: 12172137
[TBL] [Abstract][Full Text] [Related]
2. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
McCullough M; Burg M; Lin E; Peng D; Garner W
Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
[TBL] [Abstract][Full Text] [Related]
3. A 10-year experience with toxic epidermal necrolysis.
Schulz JT; Sheridan RL; Ryan CM; MacKool B; Tompkins RG
J Burn Care Rehabil; 2000; 21(3):199-204. PubMed ID: 10850900
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center.
McGee T; Munster A
Plast Reconstr Surg; 1998 Sep; 102(4):1018-22. PubMed ID: 9734418
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients treated for toxic epidermal necrolysis.
Oplatek A; Brown K; Sen S; Halerz M; Supple K; Gamelli RL
J Burn Care Res; 2006; 27(1):26-33. PubMed ID: 16566534
[TBL] [Abstract][Full Text] [Related]
6. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
[TBL] [Abstract][Full Text] [Related]
7. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
8. Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre.
Mahar PD; Wasiak J; Paul E; Watters DA; Kirby J; Gin D; Marsh P; Cleland H
Burns; 2014 Dec; 40(8):1743-7. PubMed ID: 24814156
[TBL] [Abstract][Full Text] [Related]
9. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century.
Palmieri TL; Greenhalgh DG; Saffle JR; Spence RJ; Peck MD; Jeng JC; Mozingo DW; Yowler CJ; Sheridan RL; Ahrenholz DH; Caruso DM; Foster KN; Kagan RJ; Voigt DW; Purdue GF; Hunt JL; Wolf S; Molitor F
J Burn Care Rehabil; 2002; 23(2):87-96. PubMed ID: 11882797
[TBL] [Abstract][Full Text] [Related]
10. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
11. Serum bicarbonate as a marker to predict mortality in toxic epidermal necrolysis.
Yeong EK; Lee CH; Hu FC; M Z W
J Intensive Care Med; 2011; 26(4):250-4. PubMed ID: 21887862
[TBL] [Abstract][Full Text] [Related]
12. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
[TBL] [Abstract][Full Text] [Related]
13. Long term mortality in critically ill burn survivors.
Nitzschke S; Offodile AC; Cauley RP; Frankel JE; Beam A; Elias KM; Gibbons FK; Salim A; Christopher KB
Burns; 2017 Sep; 43(6):1155-1162. PubMed ID: 28606748
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the clinical features and prognostic influencing factors of toxic epidermal necrolysis].
Hu ZX; Bian HN; Ma D; Luo HM; Sun CW; Lai W
Zhonghua Shao Shang Za Zhi; 2021 Aug; 37(8):738-746. PubMed ID: 34404158
[No Abstract] [Full Text] [Related]
15. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
[TBL] [Abstract][Full Text] [Related]
16. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.
Bastuji-Garin S; Fouchard N; Bertocchi M; Roujeau JC; Revuz J; Wolkenstein P
J Invest Dermatol; 2000 Aug; 115(2):149-53. PubMed ID: 10951229
[TBL] [Abstract][Full Text] [Related]
17. Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.
Zajicek R; Pintar D; Broz L; Suca H; Königova R
J Eur Acad Dermatol Venereol; 2012 May; 26(5):639-43. PubMed ID: 21668825
[TBL] [Abstract][Full Text] [Related]
18. The use of Biobrane
Rogers AD; Blackport E; Cartotto R
Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
[TBL] [Abstract][Full Text] [Related]
19. Differences in Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at Burn Centers and Nonburn Centers.
Nygaard RM; Endorf FW
J Burn Care Res; 2020 Sep; 41(5):945-950. PubMed ID: 32498082
[TBL] [Abstract][Full Text] [Related]
20. Toxic epidermal necrolysis: five years of treatment experience from a burn unit.
Firoz BF; Henning JS; Zarzabal LA; Pollock BH
J Am Acad Dermatol; 2012 Oct; 67(4):630-5. PubMed ID: 22285617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
